Sigilon Therapeutics Company

Sigilon is a biotech company which specializes in creating immune privileged products for unmet clinical needs.

Total Funding: 263200000
Headquarters: Cambridge, Massachusetts, United States
Employee Number: 51-100
Estimated Revenue: $10M to $50M
Last Funding Type: Post-IPO Equity
Investor Type: IPO
Last Funding Date: 2020
Investors Number: 5
Founded Date: 2015
Industry: Biotechnology